sinomenine and Edema

sinomenine has been researched along with Edema* in 6 studies

Other Studies

6 other study(ies) available for sinomenine and Edema

ArticleYear
Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis.
    Biochemical pharmacology, 2017, 10-15, Volume: 142

    Recently, microsomal prostaglandin E synthase 1 (mPGES-1) has attracted much attention from pharmacologists as a promising strategy and an attractive target for treating various types of diseases including rheumatoid arthritis (RA), which could preserve the anti-inflammatory effect while reducing the adverse effects often occur during administration of non-steroidal anti-inflammatory drugs (NSAIDs). Here, we report that sinomenine (SIN) decreased prostaglandin (PG)E

    Topics: A549 Cells; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cell Culture Techniques; Cell Survival; Edema; Female; Gene Expression; Macrophages, Peritoneal; Male; Mice, Inbred DBA; Morphinans; Prostaglandin-E Synthases; Rats, Sprague-Dawley; Transfection

2017
Role of Sinomenine on Complete Freund's Adjuvant-Induced Arthritis in Rats.
    IUBMB life, 2016, Volume: 68, Issue:6

    The investigation was undertaken to evaluate the effect of sinomenine (Sin) on experimental adjuvant arthritis rats stimulated by Freund's complete adjuvant and explore the corresponding potential molecular mechanism. The content of proinflammatory cytokines such as tumor necrosis factor-alpha, interleukin-1 beta and interleukin-6 were detected. Besides, canonical nuclear factor kappa B (NF-κB) pathway was also assessed to evaluate the antiarthritic potential of sinomenine. Pathological sections of rat paws showed sinomenine and diclofenac sodium significantly alleviated articular cartilage lesion, cellular infiltration, epithelial cell degeneration, synovial tissue vasodilation and congestion. The phosphorylations of inhibitor of kappaB alpha and NF-κB subunit p65 were downregulated with the treatment of sinomenine in dose dependent manners, as well as proinflammatory cytokines. Therefore, it was assumed that sinomenine might be a new therapeutic candidate to treat arthritis. © 2016 IUBMB Life, 68(6):429-435, 2016.

    Topics: Adaptor Proteins, Signal Transducing; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Cytokines; Edema; Freund's Adjuvant; I-kappa B Proteins; Morphinans; Nuclear Proteins; Nuclear Receptor Interacting Protein 1; Phosphorylation; Rats, Sprague-Dawley; Transcription Factor RelA

2016
Anti-inflammatory effects of novel sinomenine derivatives.
    International immunopharmacology, 2015, Volume: 29, Issue:2

    Sinomenine is an isoquinoline-type alkaloid found in Sinomenium acutum (Thunb.) Rehd. et Wils and S. acutum (Thunb.) Rehd. et Wils var. cinereum Rehd. et Wils. When used as a medicine, this compound exhibits anti-inflammatory properties; however, sinomenine's use as a medication is limited by side effects, a short half-life, and low efficacy. Owing to these limits, attempts have been made to synthesize sinomenine derivatives with enhanced efficacy. In this study, the anti-inflammatory effects of novel sinomenine derivatives (S1a-S1f) were examined on the basis of lipopolysaccharide-induced inflammatory factor expression in Raw264.7 cells, dimethylbenzene-induced ear oedema, and Evan's blue leakage in mice, and carrageenan-induced paw oedema in rats. Compared with sinomenine, the derivatives significantly inhibited the expression of the inflammatory factors IL-1β and IL-6 at the transcriptional and translational levels. Topical application of 3.250mg/kg of the derivatives also alleviated ear oedema. Compared with the vehicle, the derivatives significantly inhibited carrageenan-induced rat paw oedema after 6h. Among the derivatives, S1a exhibited the most potent anti-inflammatory activity. S1a also significantly increased the sinomenine-induced inhibition of Evan's blue leakage. Thus, S1a may elicit the strongest anti-inflammatory effects of the tested compounds. Based on these results, further development of this compound may be warranted.

    Topics: Animals; Anti-Inflammatory Agents; Capillary Permeability; Carrageenan; Coloring Agents; Edema; Evans Blue; Foot; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Male; Mice; Morphinans; Rats; Rats, Sprague-Dawley; Sinomenium; Tumor Necrosis Factor-alpha; Xylenes

2015
Microfluidics assisted synthesis and bioevaluation of sinomenine derivatives as antiinflammatory agents.
    European journal of medicinal chemistry, 2013, Volume: 62

    Sinomenine (1) is currently used for the treatment of rheumatoid arthritis (RA) in China and there is still room for the improvement of its efficacy. In present study, capillary based microfluidic system was effectively applied for the syntheses of two novel series of sinomenine derivatives. The Heck reactions in microreactor gave much higher conversions compared to the batch ones. The two-step synthesis of the isoxazoline in microreactor greatly shortened the reaction time without any isolation of intermediates. The inhibitory activity of synthesized compounds on the TNF-α-induced nuclear factor kappa B (NF-κB) activation was evaluated in vitro. Among the compounds, 3c and 3g showed the potent inhibitory activity. Furthermore, 3g exhibited the antiinflammatory effect in vivo.

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cell Survival; Dose-Response Relationship, Drug; Edema; Mice; Mice, Inbred ICR; Microfluidic Analytical Techniques; Models, Molecular; Morphinans; NF-kappa B; NIH 3T3 Cells; Structure-Activity Relationship; Tumor Necrosis Factor-alpha

2013
Development and evaluation of the Sinomenine transdermal patch.
    Pakistan journal of pharmaceutical sciences, 2008, Volume: 21, Issue:4

    Sinomenine transdermal patch was prepared and its properties were studied. The patches were produced by salivation method. The releasing rate in vitro of the patch was determined by HPLC. Peel test was used to evaluate the adhesion. Acute skin irritation test was performed in comparison with formalin (0.8%) by using mouse model. The Sinomenine TDDS Patch was prepared. The releasing rate in vitro followed the Higuchi equation (r>0.99), the releasing amount was beyond 90% in 24h. The peel adhesion to steel (N/25 mm) is 10 or above. The skin irritation tests showed negligible erythema and edema. The Sinomenine transdermal patch was prepared successfully and it may be beneficial for topical use.

    Topics: Adhesiveness; Administration, Cutaneous; Animals; Antirheumatic Agents; Chemistry, Pharmaceutical; Dosage Forms; Edema; Erythema; Excipients; Kinetics; Male; Mice; Morphinans; Permeability; Skin; Skin Absorption; Skin Irritancy Tests; Solubility; Tissue Adhesives

2008
[Synthesis and anti-inflammatory analgesic activities of sinomenine derivatives].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2004, Volume: 39, Issue:3

    To provide basic data for the synthesis of new sinomenine derivatives.. The C ring in sinomenine was modified.. Seven compounds were prepared and screened for anti-inflammatory and analgesic activities. Compounds 2 and 5 showed better activities.. Modification of the C ring in sinomenine should be worthy to be studied further.

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Edema; Mice; Molecular Conformation; Molecular Structure; Morphinans; Pain Measurement; Plants, Medicinal; Rats; Sinomenium

2004